Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Liver Transplant: early-phase trial registry
9 of 20 indexed Liver Transplant trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #848 of 28,707 conditions by registered trial count.
20 US clinical trials · 9 currently recruiting · #848 of 28,707 conditions by registered trial count
Liver Transplant: 20 US clinical trials tracked, 9 recruiting.
Liver Transplant is the subject of 20 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is TransMedics, running 4 of these trials.
Enrollment posture brief
Registry condition liver-transplant
OPEN 9 | RECR 45% | LATE 1 | EARLY 7 | RANK #848 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Germ Cell Tumor (45% recruiting · 20 trials)
Liver Transplant lists 9 open slots (45% of 20 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Liver Transplant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Liver Transplant is recruiting above its size-band peers.
9 of 20 indexed trials (45%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Liver Transplant research.
TransMedics accounts for 4 of 20 trials (20%). 14 distinct sponsors appear on at least one study for this condition label.
-
Typical Liver Transplant enrolment sits around 74 participants.
Median target enrolment is 74 among the 20 trials that report a genuine target (sentinel values excluded). 11 of those (55%) plan for fewer than 100 participants.
-
Liver Transplant splits between interventional and observational designs.
13 interventional and 7 observational studies make up this index (65% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
20 total, page 1 of 1
US National OCS Liver Perfusion (OLP) Registry
TransMedics
NCT05940857
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Northwestern University
NCT01644903
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06075745
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06280950
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Jacques E. Chelly
NCT05506878
Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool
Massachusetts General Hospital
NCT06088758
Liver Transplant CGM
Icahn School of Medicine at Mount Sinai
NCT07216508
Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue
Choon Hyuck David Kwon
NCT07102550
EVR and EPO for Liver Transplant Tolerance
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06832189
OCS Liver Perfusion (OLP) Post-Approval Registry
TransMedics
NCT05074160
Liver Transplantation With Tregs at MGH
National Institute of Allergy and Infectious Diseases (NIAID)
NCT03577431
Pediatric Liver Database
Medical College of Wisconsin
NCT00677625
Quantra QStat in Trauma and Liver Transplant
HemoSonics
NCT04312958
OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study
TransMedics
NCT05096754
OCS Liver PROTECT Continued Access Protocol
TransMedics
NCT04186221
The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients
Fernanda P Silveira, MD, MS
NCT03819322
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
University of Florida
NCT03527238
Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.
Novartis Pharmaceuticals
NCT01598987
Text Messaging for Adherence in Adolescent Liver Transplant Recipients
Stanford University
NCT01696331
Increasing Activity in Liver Transplant Patients
Mayo Clinic
NCT02058498
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Liver Transplant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Liver Transplant trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Liver Transplant page
20 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 9 Liver Transplant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- TransMedics sponsors the most Liver Transplant trials on record, review their full trial history before evaluating a specific study. See TransMedics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Liver Transplant condition card totals 20 registered trials; most-linked intervention OCS Liver; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.